
Three Maryland colleges cracked the top 100 of the 2015 Forbes’ Top Colleges list.
The schools and their rankings on the list are:
No. 27: U.S. Naval Academy No. 62: Johns Hopkins University No. 93: University of Maryland, College Park

Three Maryland colleges cracked the top 100 of the 2015 Forbes’ Top Colleges list.
The schools and their rankings on the list are:
No. 27: U.S. Naval Academy No. 62: Johns Hopkins University No. 93: University of Maryland, College Park

Chevy Chase-based New Enterprise Associates ranked among the VC firms with the best exits (meaning biggest acquisitions and initial public offerings) between 2009 and 2015, according to a new report from CB Insights.
Silicon Valley firms Sequoia Capital and Accel Partners were also included at the top of the list.

A gel being developed in the lab at Johns Hopkins University is designed to make all signs of wounds disappear.
Gemstone Biotherapeutics, which focuses on wound care, grew out of the research of Hopkins engineering professor Sharon Gerecht. The winner of Hopkins’ first-ever President’s Frontier Award, Gerecht’s work is focused on tissue repair.
![]()
MedImmune has received a state award recognizing the company’s commitment to environmentally conscious practices.
Maryland’s Green Registry announced Thursday that MedImmune was one of its five 2015 Leadership Award winners.

GenArraytion, Inc., is pleased to announce a manufacturing license agreement with Chemring Detection Systems, Inc. (“CDS”), a subsidiary of Chemring Sensors & Electronic Systems (CSES) and part of Chemring Group PLC (“Chemring”), in support of the development of the Commercial-Off-the-Shelf (COTS) Athina Consumable Cartridge product. GenArraytion will provide a highly multiplexed molecular assay panel on Luminex magnetic beads that will detect multiple biological warfare agents in a single reaction as part of the Athina Consumable Cartridge solution.
CDS was awarded a $14,934,533 cost-plus-incentive-fee incrementally funded JBTDS contract with options last month. The Athina product technology is the basis for the awarded JBTDS solution. Fiscal year 2015 research, development, testing and evaluation funds in the amount of $4,456,639 were obligated at the time of the award. CSES was granted the contract after an evaluation and selection process that began in early 2014.

Three venture firms stand out in a new study by CB Insight of who consistently enjoyed the biggest exits — IPOs or sales — of their portfolio companies.
Sequoia Capital, Accel Partners and New Enterprise Associates had at least five of the top exits in two windows used in the study. They were the only ones to be in the top five for both periods used in the CB Insights research.

Three American universities are set to conduct wide-ranging research on cryptocurrencies using roughly $3m in grant funding from the National Science Foundation, a US government agency that supports and funds scientific research.
Cornell, the University of Maryland and the University of California Berkeley will focus on developing new cryptocurrency systems that, according to principal investigator Elaine Shi, will address “pain points” attributed to bitcoin and other existing networks.
T
he Pentagon today awarded its years-in-the-making multibillion contract to upgrade its electronic health records system, to defense IT firm Leidos, which partnered with electronic health record vendor Cerner and Accenture Federal.
The Defense Healthcare Management Systems Modernization contract’s base value is $4.3 billion over 10 years, with an expected 18-year lifecycle value of $9 billion, and will put Leidos in charge of building a next-generation health records system responsible for DOD’s 9.6 million beneficiaries.

Developing lab research into the foundations of a profitable biotech company has always been a high-risk, high-reward business.
Deerfield Management, a New York-based healthcare investor with more than $5 billion under management and two decades of experience, has created a new $550 million fund that targets early stage science from academic medical centers and hospitals. The fund is specifically focused on innovative treatments for genetic disorders, cancer, and orphan diseases.

Event is open to Post-Docs & Professional Scientists currently work in the Therapeutic Areas of:
Business roles who support the groups above should also register!
Event will include music, lawn games, hors d’oeuvres, and drinks